# AKY15-HK-301_NEPA Study

> **NCT03386617** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 55 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** NEPA

## Key facts

- **NCT ID:** NCT03386617
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-02-27
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03386617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03386617, "AKY15-HK-301_NEPA Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03386617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*